Clinicians Want AI Education That Knows the Job to Be Done
Earlier coverage of ai oversight and its implications for CME providers.
A narrow AI signal this week: the more credible educational offer covers implementation decisions and responsible-use constraints together.
This week’s AI discussion pointed less to orientation and more to operational-readiness training with explicit limits built in. Because the evidence comes mainly from podcast, editorial, and organization-voiced sources rather than broad frontline clinician conversation, this is best read as an emerging design signal, not a settled cross-specialty shift.
Across this week’s sources, the question was less "Should we use AI?" than who owns each step, where orders or tasks should route, how tools connect to the EHR, what happens when vendors are fragmented, and how clinicians should handle confidentiality, disclosure, fairness, and accountability in the same use case. In diabetes technology, one Medscape discussion on operationalizing automated insulin delivery focused on staffing ownership, payer routing, ordering pathways, and documentation barriers rather than clinical hesitation alone (Medscape). A JAMA audio interview made a similar point about AI products: standalone tools become harder to use when clinicians must manage disconnected vendors or separate interfaces outside the EHR (JAMA+ AI Conversations).
The other half of the signal is that responsible use is not being treated as a separate ethics add-on. JAMA Health Forum discussion tied AI deployment directly to accountability, trust, proficiency, and equity risk (JAMA Health Forum Conversations). Academic Medicine contributors emphasized confidentiality, professional accountability, transparency, and fair-mindedness in AI use (Academic Medicine Podcast). A BMJ roundtable likewise kept human accountability and trust in view as AI enters clinical information use (BMJ Podcast). This builds on our earlier brief on supervised delegation in AI education: not just keeping humans in charge, but teaching how that responsibility is carried out in practice.
For CME providers, that changes what a credible AI activity looks like. A stronger format is a role-specific scenario: who initiates use, who reviews output, what gets documented, when disclosure is needed, what bias or equity checks are required, and where escalation happens when the tool is wrong or incomplete. Given this week’s limited and largely organization-voiced evidence, the implication is not to rebuild the whole AI portfolio. It is to ask whether the next AI activity leaves learners with a usable operating approach rather than a better opinion about the technology.
Earlier coverage of ai oversight and its implications for CME providers.
Earlier coverage of ai oversight and its implications for CME providers.
Earlier coverage of ai oversight and its implications for CME providers.
ChatCME surfaces the questions clinicians actually ask — so you can build activities that close real knowledge gaps.
Request a demo